therapeutic

Gantenerumab

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Gantenerumab: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

10Connections
0Hypotheses
0Analyses
8Outgoing
2Incoming
0Experiments

Summary

<table class="infobox infobox-therapeutic">

View on Wiki →

💊 Therapeutic Info
NameGantenerumab
SummaryPage for Gantenerumab

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Gantenerumab

entity · 949 words

Therapeutics

index · 5665 words

Alzheimer's Disease

disease · 5265 words

DIAN-TU-001 Trial (NCT01760005)

clinical · 4560 words

Blood-Brain Barrier Biology and Crossing Strategies

mechanism · 4474 words

PMN310 Anti-Amyloid for AD (NCT06750432)

clinical · 4244 words

Pathway Diagram

flowchart TD
    N0["Gantenerumab"]
    N1["ALZHEIMER'S DISEASE"]
    N1 -->|"associated with"| N0
    N2["ADUCANUMAB"]
    N0 -->|"associated with"| N2
    N3["LECANEMAB"]
    N0 -->|"associated with"| N3
    N4["DONANEMAB"]
    N0 -->|"associated with"| N4
    N5["SOLANEZUMAB"]
    N0 -->|"associated with"| N5
    N6["CRENEZUMAB"]
    N0 -->|"associated with"| N6
    N7["AMYLOID"]
    N0 -->|"associated with"| N7
    N8["TAU"]
    N0 -->|"associated with"| N8

    classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
    classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
    classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
    classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
    classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
    classDef drug fill:#1a2a2a,stroke:#26c6da,color:#e0e0e0
    classDef cell_type fill:#2a1a2a,stroke:#ab47bc,color:#e0e0e0
    classDef phenotype fill:#2a2a1a,stroke:#ffa726,color:#e0e0e0
    classDef process fill:#1a2a2a,stroke:#66bb6a,color:#e0e0e0
    classDef biological_process fill:#1a2a2a,stroke:#66bb6a,color:#e0e0e0
    classDef concept fill:#1a1a2a,stroke:#7986cb,color:#e0e0e0
    classDef entity fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
    classDef therapeutic fill:#1a2a2a,stroke:#26c6da,color:#e0e0e0
    classDef index fill:#1a1a2a,stroke:#7986cb,color:#e0e0e0
    class N0 therapeutic
    class N1 disease
    class N2 drug
    class N3 drug
    class N4 drug
    class N5 drug
    class N6 drug
    class N7 protein
    class N8 protein

Outgoing (8)

TargetRelationTypeStr
SOLANEZUMABassociated_withdrug0.45
CRENEZUMABassociated_withdrug0.45
TAUassociated_withprotein0.45
ADUCANUMABassociated_withdrug0.45
LECANEMABassociated_withdrug0.45

Incoming (2)

SourceRelationTypeStr
ALZHEIMER'S DISEASEassociated_withdisease0.45
ad_clinical_trial_failures:gantenerumabdata_indataset_row0.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found